Bank Pictet & Cie (Asia)’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $4.78M | Buy |
38,605
+4,555
| +13% | +$587K | 0.3% | 18 |
|
|
2024
Q1 | $4.49M | Buy |
34,050
+6,863
| +25% | +$846K | 0.35% | 14 |
|
|
2023
Q4 | $2.96M | Buy |
27,187
+2,180
| +9% | +$226K | 0.75% | 22 |
|
|
2023
Q3 | $2.57M | Buy |
25,007
+490
| +2% | +$52.8K | 0.76% | 25 |
|
|
2023
Q2 | $2.83M | Buy |
24,517
+11,230
| +85% | +$1.28M | 0.83% | 23 |
|
|
2023
Q1 | $1.41M | Sell |
13,287
-93
| -0.7% | -$10K | 0.48% | 38 |
|
|
2022
Q4 | $1.48M | Sell |
13,380
-480
| -3% | -$49.1K | 0.53% | 36 |
|
|
2022
Q3 | $1.19M | Sell |
13,860
-238
| -2% | -$21.2K | 0.47% | 35 |
|
|
2022
Q2 | $1.28M | Buy |
14,098
+132
| +0.9% | +$11.7K | 0.43% | 38 |
|
|
2022
Q1 | $1.15M | Hold |
13,966
| – | – | 0.31% | 70 |
|
|
2021
Q4 | $1.07M | Buy |
13,966
+1,900
| +16% | +$151K | 0.25% | 74 |
|
|
2021
Q3 | $906K | Sell |
12,066
-86
| -0.7% | -$6.54K | 0.25% | 74 |
|
|
2021
Q2 | $945K | Sell |
12,152
-59
| -0.5% | -$4.39K | 0.26% | 69 |
|
|
2021
Q1 | $898K | Buy |
12,211
+1,597
| +15% | +$118K | 0.28% | 70 |
|
|
2020
Q4 | $828K | Buy |
10,614
+921
| +10% | +$70.4K | 0.26% | 71 |
|
|
2020
Q3 | $767K | Hold |
9,693
| – | – | 0.3% | 69 |
|
|
2020
Q2 | $715K | Sell |
9,693
-576
| -6% | -$43.4K | 0.31% | 66 |
|
|
2020
Q1 | $754K | Buy |
10,269
+2,836
| +38% | +$223K | 0.36% | 53 |
|
|
2019
Q4 | $645K | Buy |
7,433
+97
| +1% | +$7.97K | 0.28% | 71 |
|
|
2019
Q3 | $589K | Hold |
7,336
| – | – | 0.27% | 68 |
|
|
2019
Q2 | $587K | Hold |
7,336
| – | – | 0.27% | 68 |
|
|
2019
Q1 | $582K | Hold |
7,336
| – | – | 0.28% | 68 |
|
|
2018
Q4 | $535K | Hold |
7,336
| – | – | 0.29% | 67 |
|
|
2018
Q3 | $497K | Hold |
7,336
| – | – | 0.23% | 74 |
|
|
2018
Q2 | $425K | Hold |
7,336
| – | – | 0.19% | 78 |
|
|
2018
Q1 | $381K | Hold |
7,336
| – | – | 0.18% | 46 |
|
|
2017
Q4 | $394K | Hold |
7,336
| – | – | 0.17% | 52 |
|
|
2017
Q3 | $448K | Hold |
7,336
| – | – | 0.21% | 47 |
|
|
2017
Q2 | $449K | Sell |
7,336
-16,665
| -69% | -$1.01M | 0.21% | 44 |
|
|
2017
Q1 | $1.46M | Hold |
24,001
| – | – | 0.66% | 32 |
|
|
2016
Q4 | $1.35M | Hold |
24,001
| – | – | 0.69% | 30 |
|
|
2016
Q3 | $1.43M | Sell |
24,001
-14,651
| -38% | -$857K | 0.83% | 28 |
|
|
2016
Q2 | $2.13M | Sell |
38,652
-556
| -1% | -$29.6K | 1.36% | 27 |
|
|
2016
Q1 | $1.98M | Sell |
39,208
-105
| -0.3% | -$5.14K | 1.17% | 30 |
|
|
2015
Q4 | $1.98M | Buy |
39,313
+1,415
| +4% | +$71.3K | 1.15% | 30 |
|
|
2015
Q3 | $1.79M | Buy |
+37,898
| New | +$2.01M | 1.32% | 26 |
|
|
2015
Q2 | – | Sell |
-10,136
| Closed | -$556K | – | 69 |
|
|
2015
Q1 | $556K | Buy |
10,136
+2,234
| +28% | +$126K | 0.41% | 37 |
|
|
2014
Q4 | $428K | Sell |
7,902
-1,572
| -17% | -$87.6K | 0.33% | 48 |
|
|
2014
Q3 | $536K | Buy |
9,474
+3,301
| +53% | +$185K | 0.39% | 40 |
|
|
2014
Q2 | $341K | Sell |
6,173
-1,257
| -17% | -$68.6K | 0.43% | 41 |
|
|
2014
Q1 | $402K | Sell |
7,430
-1,918
| -21% | -$99.3K | 0.25% | 43 |
|
|
2013
Q4 | $446K | Buy |
+9,348
| New | +$427K | 0.3% | 46 |
|
Other funds holding MRK
Bank Pictet & Cie (Asia)'s MRK Position: Q2 2024 in Review
Bank Pictet & Cie (Asia) increased its Merck (MRK) stake by 13% in Q2 2024, buying an estimated $587K and bringing the position to 38,605 shares worth $4.78M. The position accounts for 0.3% of the portfolio, ranked #18.
Bank Pictet & Cie (Asia) first reported a position in MRK in Q4 2013 and has held it in 42 quarters since. 3,546 funds tracked by Wall St. Rank hold MRK as of Q2 2024.
- Bank Pictet & Cie (Asia) held 38,605 shares of Merck worth $4.78M as of Q2 2024.
- Bank Pictet & Cie (Asia) bought 4,555 Merck shares in Q2 2024, an estimated $587K.
- Merck made up 0.3% of Bank Pictet & Cie (Asia)'s portfolio in Q2 2024, its #18 holding.
- Bank Pictet & Cie (Asia) first reported a position in Merck in Q4 2013 and has held it in 42 quarters since.
- 3,546 funds tracked by Wall St. Rank held Merck as of Q2 2024.
Based on Bank Pictet & Cie (Asia)'s 13F filing for Q2 2024, filed 16 Jul 2024.